Caribou Biosciences, Inc. (CRBU)
Nasdaq: CRBU · Biological Products, (No Diagnostic Substances) · Berkeley, CA · filing with the SEC since 2014
Who runs Caribou Biosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Haurwitz Rachel E.
President and CEO. First filing Jul 2021, latest Feb 20, 2026, 1 filing in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
18 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kelly Timothy P | Chief Technology Officer | Jan 2024 | Feb 27, 2026 | 2 · $0.00 |
| Albertson Tina M. | Chief Medical Officer | Aug 2024 | Feb 24, 2026 | 1 · $0.00 |
| Khan Ruhi Ahmad | Chief Business Officer | Nov 2021 | Feb 24, 2026 | 1 · $0.00 |
| Mcclung Barbara G | Chief Legal Officer | Jul 2021 | Feb 24, 2026 | 1 · $0.00 |
| Haurwitz Rachel E. | President and CEO | Jul 2021 | Feb 20, 2026 | none |
| Ryali Sriram | Chief Financial Officer | Jan 2025 | Feb 20, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Braunstein Scott | director | Jul 2021 | Feb 20, 2026 | none |
| Guggenhime Andrew | director | Jul 2021 | Feb 20, 2026 | none |
| Johnson David Lee | director | May 2022 | Feb 20, 2026 | none |
| Richardson-Heron Dara | director | Nov 2021 | Feb 20, 2026 | none |
| Sacks Natalie | director | Jul 2021 | Feb 20, 2026 | none |
| Whiting Nancy | director | Aug 2021 | Feb 20, 2026 | none |
| Zheng Ran | director | Oct 2021 | Feb 20, 2026 | none |
Earlier names on the record6, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.